Literature DB >> 33266046

A New Insight on the Radioprotective Potential of Epsilon-Aminocaproic Acid.

Timur Saliev1, Dinara Baiskhanova2, Dmitriy Beznosko3, Dinara Begimbetova2, Bauyrzhan Umbayev2, Talgat Nurgozhin1, Ildar Fakhradiyev1, Baimakhan Tanabayev4, Dainius Pavalkis5.   

Abstract

Background and objectives: The aim of the study was to scrutinize the ability of epsilon-aminocaproic acid (EACA) to prevent radiation-induced damage to human cells. Materials and
Methods: Human peripheral blood mononuclear cells (PBMCs) were exposed to ionizing radiation at three low doses (22.62 mGy, 45.27 mGy, and 67.88 mGy) in the presence of EACA at the concentration of 50 ng/mL.
Results: EACA was able to prevent cell death induced by low-dose X-ray radiation and suppress the formation of reactive oxygen species (ROS). EACA also demonstrated a capacity to protect DNA from radiation-induced damage. The data indicated that EACA is capable of suppression of radiation-induced apoptosis. Comparative tests of antioxidative activity of EACA and a range of free radical scavengers showed an ability of EACA to effectively inhibit the generation of ROS. Conclusions: This study showed that the pretreatment of PBMCs with EACA is able to protect the cells from radiation-elicited damage, including free radicals' formation, DNA damage, and apoptosis.

Entities:  

Keywords:  DNA damage; apoptosis; epsilon-aminocaproic acid; protection; radiation; reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 33266046      PMCID: PMC7760922          DOI: 10.3390/medicina56120663

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  102 in total

1.  Inhibition of proteolytic processing of adenoviral proteins by epsilon-aminocaproic acid and ambenum in adenovirus-infected cells.

Authors:  Lidiya Nosach; Nataliya Dyachenko; Valentina Zhovnovataya; Miron Lozinskiy; Victor Lozitsky
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

2.  Effects of low-dose gamma radiation on DNA damage, chromosomal aberration and expression of repair genes in human blood cells.

Authors:  Wanwisa Sudprasert; Panida Navasumrit; Mathuros Ruchirawat
Journal:  Int J Hyg Environ Health       Date:  2006-07-26       Impact factor: 5.840

Review 3.  Radioprotective agents for radiation therapy: future trends.

Authors:  Roberta M Johnke; Jennifer A Sattler; Ron R Allison
Journal:  Future Oncol       Date:  2014-12       Impact factor: 3.404

4.  Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid).

Authors:  Ilhami Gülçin
Journal:  Toxicology       Date:  2005-10-21       Impact factor: 4.221

5.  Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss.

Authors:  B N Phenix; J J Lum; Z Nie; J Sanchez-Dardon; A D Badley
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

Review 6.  Ionizing radiation-induced oxidative stress, epigenetic changes and genomic instability: the pivotal role of mitochondria.

Authors:  Irena Szumiel
Journal:  Int J Radiat Biol       Date:  2015-01       Impact factor: 2.694

7.  Comparison of behavioral and radioprotective effects of WR-2721 and WR-3689.

Authors:  J H McDonough; P C Mele; C G Franz
Journal:  Pharmacol Biochem Behav       Date:  1992-06       Impact factor: 3.533

8.  Severe mitochondrial damage associated with low-dose radiation sensitivity in ATM- and NBS1-deficient cells.

Authors:  Tsutomu Shimura; Junya Kobayashi; Kenshi Komatsu; Naoki Kunugita
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Radioprotection by two phenolic compounds: chlorogenic and quinic acid, on X-ray induced DNA damage in human blood lymphocytes in vitro.

Authors:  Nilufer Cinkilic; Sibel Kahraman Cetintas; Tolga Zorlu; Ozgur Vatan; Dilek Yilmaz; Tolga Cavas; Sema Tunc; Lutfi Ozkan; Rahmi Bilaloglu
Journal:  Food Chem Toxicol       Date:  2012-12-21       Impact factor: 6.023

Review 10.  Radioprotectors and mitigators of radiation-induced normal tissue injury.

Authors:  Deborah Citrin; Ana P Cotrim; Fuminori Hyodo; Bruce J Baum; Murali C Krishna; James B Mitchell
Journal:  Oncologist       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.